KO Research Update — June 20, 2026
Updated Thesis
The Coca-Cola Company is a leading global branded beverages company with a very wide moat in sparkling soft drinks and non-alcoholic ready-to-drink beverages. It benefits from strong pricing power, stable margins, and high recurring cash flow, supported by a seasoned management team with deep company tenure. Despite solid recent growth with revenue up 12.1% and earnings up 17.8% in the most recent quarter, the stock is currently overvalued, trading about 10% above its fair value estimate of $71.54 at $79.39.
The investment grade as of this refresh is D — solid business quality. High-tier business, expensive valuation with 9.9% downside to $71.54 fair value
Key Metrics at a Glance
- Revenue growth: +12.1% year over year
- Net margin: 27.8%
- Forward P/E: 24.9x
- Fair value upside: -9.9% to our estimate of $72
Current price: $79.39
These figures reflect our most recent data pull and are one input into a multi-factor valuation framework.
Our 12–18 Month Outlook
Quality companies held over a multi-year horizon benefit from compounding fundamentals and the patience to ride through short-term volatility. The Coca-Cola Company remains in our covered universe with a solid-quality assessment. We update research when material data changes — earnings revisions, management shifts, or regime changes in valuation — not on every price fluctuation.
Long-term accumulation of quality businesses at fair or better prices is the core of the Patient Accumulator approach. Research updates like this one inform whether to add, hold, or wait for a better zone — not whether to react to short-term price moves.
[View full KO research →](/stocks/KO)